Grants and Contributions:
Agreement Number:
-
Agreement Value:
$703,800.00
Agreement Date:
Apr 1, 2018 - Mar 31, 2022
Description:
Pilot study of emtricitabine, tenofovir alafenamide and raltegravir for patients with primary biliary cholangitis
Organization:
Canadian Institutes of Health Research
Location:
Edmonton, Alberta, CA T6G 2E1
Reference Number:
236-2017-2018-Q4-00868
Agreement Type:
Grant
Report Type:
Grants and Contributions
Additional Information:
Grant or Award spanning more than one fiscal year.
(2018-19 to 2021-22)
Recipient's Legal Name:
Mason, Andrew L
Research Organization:
University of Alberta